Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.06 - $1.97 $1.51 Million - $2.8 Million
-1,420,266 Reduced 72.46%
539,679 $599,000
Q4 2022

Feb 14, 2023

BUY
$1.4 - $25.4 $1.06 Million - $19.2 Million
755,326 Added 62.7%
1,959,945 $2.86 Million
Q3 2022

Nov 14, 2022

SELL
$0.36 - $36.0 $289,480 - $28.9 Million
-804,112 Reduced 40.03%
1,204,619 $2.21 Million
Q2 2022

Aug 15, 2022

BUY
$12.3 - $27.3 $15.2 Million - $33.8 Million
1,236,369 Added 160.08%
2,008,731 $2.77 Million
Q1 2022

May 16, 2022

SELL
$16.6 - $32.3 $44.8 Million - $87.3 Million
-2,701,802 Reduced 77.77%
772,362 $1.99 Million
Q4 2021

Feb 14, 2022

BUY
$29.9 - $61.2 $96.1 Million - $197 Million
3,212,805 Added 1229.27%
3,474,164 $0
Q3 2021

Nov 15, 2021

BUY
$51.4 - $68.2 $5.54 Million - $7.36 Million
107,846 Added 70.25%
261,359 $1.44 Million
Q2 2021

Aug 16, 2021

SELL
$44.1 - $84.0 $104 Million - $199 Million
-2,365,277 Reduced 93.91%
153,513 $0
Q1 2021

May 17, 2021

BUY
$47.0 - $155.7 $118 Million - $392 Million
2,518,790 New
2,518,790 $20.4 Million
Q4 2020

Feb 16, 2021

SELL
$4.8 - $30.8 $204,374 - $1.31 Million
-42,578 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$4.7 - $8.9 $834,621 - $1.58 Million
-177,579 Reduced 80.66%
42,578 $28,000
Q2 2020

Aug 14, 2020

BUY
$2.6 - $5.7 $572,408 - $1.25 Million
220,157 New
220,157 $112,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $133M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.